APP and Alzheimer disease: Markedly, the present study investigated the dysregulated lncRNAs and their associated mRNAs in the development and/or progression of AD, using the APP/PS1 transgenic mouse model that is reported as a well-known model presenting vital AD symptoms such as Aβ accumulation and cognitive decline from young age [29].